Lingli Liang
- Physiology top 1%
- Pain Mechanisms and Treatments 39
-
- Nerve injury and regeneration 11
- Hereditary Neurological Disorders 6
- Neuropeptides and Animal Physiology 4
- Neuroscience and Neuropharmacology Research 4
- Sensory Systems top 2%
- Cancer Research top 10%
-
- Histone Deacetylase Inhibitors Research 5
-
- Botulinum Toxin and Related Neurological Disorders 4
-
- Cancer Treatment and Pharmacology 4
- Co-authors
- Yuan‐Xiang TaoAlex BekkerBrianna Marie LutzShaogen WuJian‐Yuan ZhaoKai MoFidelis E. AtianjohYu‐Qiu Zhang
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lingli Liang
54 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 106
- Physiology 1.4k
- Cellular and Molecular Neuroscience 772
- Sensory Systems 152
- Anesthesiology and Pain Medicine 109
- Cancer Research 245
Countries citing papers authored by Lingli Liang
This map shows the geographic impact of Lingli Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Liang more than expected).
Fields of papers citing papers by Lingli Liang
This network shows the impact of papers produced by Lingli Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Liang. The network helps show where Lingli Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingli Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 24 | |
| 13 | 2019 | 24 | |
| 14 | 2019 | 10 | |
| 15 | 2019 | 29 | |
| 16 | 2019 | 51 | |
| 17 | 2017 | 153 | |
| 18 | 2017 | 55 | |
| 19 | 2017 | 16 | |
| 20 | 2013 | 46 |
About Lingli Liang
Lingli Liang is a scholar working on Physiology, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 57 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (39 papers), Nerve injury and regeneration (11 papers), Hereditary Neurological Disorders (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Botulinum Toxin and Related Neurological Disorders (4 papers), Neuropeptides and Animal Physiology (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Physiology (1.4k citations), Cellular and Molecular Neuroscience (772 citations) and Sensory Systems (152 citations). Lingli Liang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yuan‐Xiang Tao, Alex Bekker, Brianna Marie Lutz, Shaogen Wu, Jian‐Yuan Zhao, Kai Mo, Fidelis E. Atianjoh, Yu‐Qiu Zhang, Xiyao Gu and Vinod Tiwari. Their work appears in journals such as Neuropharmacology, Molecular Pain, Journal of Pain, Pain and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.